Neuroprotective fractalkine in fetal alcohol syndrome

American Journal of Obstetrics and Gynecology

Volumn 204, Issue 5, 2011, Pages 400.e1-400.e3

  Roberson, Robin ^a   Kuddo, Thea ^a   Benassou, Ines ^a   Abebe, Daniel ^a   Spong, Catherine ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

fetal alcohol syndrome; fractalkine; NAPVSIPQ; SALLRSIPA

Indexed keywords

ALCOHOL; DAVUNETIDE; FRACTALKINE; NEUROPROTECTIVE AGENT; PEPTIDE; PLACEBO; PROTEIN HYDROLYSATE; SERYLALANYLLEUCYLLEUCYLARGINYLSERYLISOLEUCYLPROLYLALANINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; EMBRYO; FEMALE; FETAL ALCOHOL SYNDROME; FETUS; MOUSE; NEUROPROTECTION; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 79955586565     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.03.034     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention Behavioral risk factor surveillance system http://www.cdc.gov/brfss Accessed Sept. 2008
2. R.J. Sokol, V. Delaney-Black, and B. Nordstrom Fetal alcohol spectrum disorder JAMA 290 2003 2996 2999 (Pubitemid 37505533)
3. C.Y. Spong, D.T. Abebe, I. Gozes, D.E. Brenneman, and J.M. Hill Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome J Pharmacol Exp Ther 297 2001 774 779 (Pubitemid 32378011)
4. J. Vink, J. Auth, D.T. Abebe, D.E. Brenneman, and C.Y. Spong Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome Am J Obstet Gynecol 193 2005 825 829 (Pubitemid 41261483)
5. J. Vink, J. Auth, D.T. Abebe, D.E. Brenneman, and C.Y. Spong Novel peptides prevent alcohol-induced spatial learning deficits and proinflammatory cytokine release in a mouse model of fetal alcohol syndrome Am J Obstet Gynecol 193 2005 825 829 (Pubitemid 41261483)
6. D. Balschun, W. Wetzel, and A. Del Rey Interleukin-6: a cytokine to forget FASEB J 18 2004 1788 1790 (Pubitemid 39561685)
7. Q. Wang, J. Wu, M.J. Rowan, and R. Anwyl Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor Eur J Neurosci 22 2005 2827 2832 (Pubitemid 41811280)
8. B.A. Jones, M. Beamer, and S. Ahmed Fractalkine/CX3CL1: a potential new target for inflammatory diseases Mol Interv 10 2010 263 270
9. W.S. Webster, D.A. Walsh, A.H. Lipson, and S.E. McEwen Teratogenesis after acute alcohol exposure in inbred and outbred mice Neurotoxicol Teratol 2 1980 227 234 (Pubitemid 11160281)
10. D. Sunnemark, S. Eltayeb, and M. Nilsson CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin J Neuroinflamm 29 2005 17
11. A.E. Cardona, E.P. Pioro, and M.E. Sasse Control of microglial neurotoxicity by the fractalkine receptor Nat Neurosci 9 2006 917 924 (Pubitemid 43980506)
12. Y.J. Gao, and R.R. Ji Chemokines, neuronal-glial interactions, and central processing of neuropathic pain Pharmacol Ther 126 2010 56 68
13. L. Toso, I. Cameroni, R. Roberson, D. Abebe, S. Bissell, and C.Y. Spong Prevention of developmental delays in a Down syndrome mouse model Obstet Gynecol 112 2008 1242 1251
14. F. Ginhoux, M. Greter, and M. Leboeuf Fate mapping analysis reveals that adult microglia derive from primitive macrophages Science 330 2010 841 845
15. L. Maggi, F. Trettel, and M. Scianni LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R) J Neuroimmunol 215 2009 36 42
16. T.J. Shors, and P.R. Mathew NMDA receptor antagonism in the lateral/basolateral but not central nucleus of the amygdala prevents the induction of facilitated learning in response to stress Learn Mem 5 1998 220 230 (Pubitemid 29108881)
17. A.D. Bachstetter, J.M. Morganti, and J. Jernberg Fractalkine and CX(3)CR1 regulate hippocampal neurogenesis in adult and aged rats Neurobiol Aging 2009 Epub ahead of print